Additional information
White Powder
334981-35-0
ACI-015214
N-methyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine
N-methyl-2-5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-ylethanamine
227.3-228.9°C
C18H25N3O6S
411.47
Ambient
2-8°C
1H-Indole-3-ethanamine, N-methyl-5-[(1-pyrrolidinylsulfonyl)methyl]-, ethanedioate
Neurological disorder
Pharmaceutical Impurity Standards





![BUTOXYQUINOLINONE BREXPIPRAZOLE (25 mg) (7-[4-(7-{4-[4-(Benzo[b]thiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2-yloxy)butoxy]quinolin-2(1H)-one)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)